£37.00
Additional information
| Active substance | Candesartan Cilexetil |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitoring of blood pressure and renal function may be required |
| Also known as | Candesartan |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Effectively lowers blood pressure |
| Trade name | Atacand |
| Storage conditions | Store at room temperature, protect from moisture and light |
| Chemical name | 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate |
| Formula | C33H34N6O6 |
| Substance class | Angiotensin II receptor blocker |
| Main action | Blocks the action of angiotensin II, resulting in vasodilation and reduction in blood pressure |
| Half-life | Approximately 9 hours |
| Dosage (medical) | Typically 8-32 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Lowers blood pressure, reduces strain on the heart, may improve survival after heart attacks |
| Side effects | Dizziness, headache, back pain, sore throat, abdominal pain, diarrhea |
| Use in sports | Not typically used in sports for performance enhancement |
| Manufacturer | AstraZeneca |
